0

Cardiology Collection
 201-220 of 4883 Articles
Articles |  2 June 2009
Two Risk-Scoring Systems for Predicting Incident Diabetes Mellitus in U.S. Adults Age 45 to 64 Years
Henry S. Kahn, MD; Yiling J. Cheng, MD, PhD; Theodore J. Thompson, MS; et al.
Ann Intern Med. 2009;150(11):741-751. doi:10.7326/0003-4819-150-11-200906020-00002
Reviews |  2 June 2009
Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension
James R. Sowers, MD; Adam Whaley-Connell, DO; Murray Epstein, MD
Ann Intern Med. 2009;150(11):776-783. doi:10.7326/0003-4819-150-11-200906020-00005
Reviews |  2 June 2009
Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
Finlay A. McAlister, MD, MSc; Natasha Wiebe, MMath, PStat; Justin A. Ezekowitz, MD, MSc; et al.
Ann Intern Med. 2009;150(11):784-794. doi:10.7326/0003-4819-150-11-200906020-00006
Academia and the Profession |  2 June 2009
Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures
Nancy R. Cook, ScD; Paul M Ridker, MD
Ann Intern Med. 2009;150(11):795-802. doi:10.7326/0003-4819-150-11-200906020-00007
Ideas and Opinions |  2 June 2009
Glycemic Control in Type 2 Diabetes: Time for an Evidence-Based About-Face?
Victor M. Montori, MD, MSc; Mercè Fernández-Balsells, MD
Ann Intern Med. 2009;150(11):803-808. doi:10.7326/0003-4819-150-11-200906020-00008
Editorials |  2 June 2009
Predicting Risk for Diabetes: Choosing (or Building) the Right Model
William H. Herman, MD, MPH
Ann Intern Med. 2009;150(11):812-814. doi:10.7326/0003-4819-150-11-200906020-00010
Improving Patient Care |  19 May 2009
Shop for Quality or Volume? Volume, Quality, and Outcomes of Coronary Artery Bypass Surgery
Andrew D. Auerbach, MD, MPH; Joan F. Hilton, ScD; Judith Maselli, MSPH; et al.
Ann Intern Med. 2009;150(10):696-704. doi:10.7326/0003-4819-150-10-200905190-00007
Academia and the Profession |  19 May 2009
Current Guidelines for Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin II–Receptor Antagonists in Chronic Kidney Disease: Is the Evidence Base Relevant to Older Adults?
Ann M. O'Hare, MD; James S. Kaufman, MD; Kenneth E. Covinsky, MD, MPH; et al.
Ann Intern Med. 2009;150(10):717-724. doi:10.7326/0003-4819-150-10-200905190-00010
Articles |  5 May 2009
Health Care–Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition
Natividad Benito, MD, PhD; José M. Miró, MD, PhD; Elisa de Lazzari, MSs; et al.
Ann Intern Med. 2009;150(9):586-594. doi:10.7326/0003-4819-150-9-200905050-00004
Articles |  21 April 2009 FREE
Differences in Control of Cardiovascular Disease and Diabetes by Race, Ethnicity, and Education: U.S. Trends From 1999 to 2006 and Effects of Medicare Coverage
J. Michael McWilliams, MD, PhD; Ellen Meara, PhD; Alan M. Zaslavsky, PhD; et al.
Ann Intern Med. 2009;150(8):505-515. doi:10.7326/0003-4819-150-8-200904210-00005
Articles |  21 April 2009 FREE
Using a Drug Facts Box to Communicate Drug Benefits and Harms: Two Randomized Trials
Lisa M. Schwartz, MD, MS; Steven Woloshin, MD, MS; H. Gilbert Welch, MD, MPH
Ann Intern Med. 2009;150(8):516-527. doi:10.7326/0003-4819-150-8-200904210-00106
Articles |  21 April 2009
Joint Effects of Common Genetic Variants on the Risk for Type 2 Diabetes in U.S. Men and Women of European Ancestry
Marilyn C. Cornelis, PhD; Lu Qi, MD, PhD; Cuilin Zhang, MD, PhD; et al.
Ann Intern Med. 2009;150(8):541-550. doi:10.7326/0003-4819-150-8-200904210-00008
Editorials |  21 April 2009 FREE
Communicating Drug Benefits and Risks Effectively: There Must Be a Better Way
Jerry Avorn, MD; William H. Shrank, MD, MSHS
Ann Intern Med. 2009;150(8):563-564. doi:10.7326/0003-4819-150-8-200904210-00012
Articles |  7 April 2009
Effect of Varying Levels of Disease Management on Smoking Cessation: A Randomized Trial
Edward F. Ellerbeck, MD, MPH; Jonathan D. Mahnken, PhD; A. Paula Cupertino, PhD; et al.
Ann Intern Med. 2009;150(7):437-446. doi:10.7326/0003-4819-150-7-200904070-00003
Articles |  7 April 2009
Triple-Combination Pharmacotherapy for Medically Ill Smokers: A Randomized Trial
Michael B. Steinberg, MD, MPH; Shelley Greenhaus, RN, MPH; Amy C. Schmelzer, MS; et al.
Ann Intern Med. 2009;150(7):447-454. doi:10.7326/0003-4819-150-7-200904070-00004
Reviews |  7 April 2009
Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes
Stanley Ip, MD; Alice H. Lichtenstein, ScD; Mei Chung, MPH; et al.
Ann Intern Med. 2009;150(7):474-484. doi:10.7326/0003-4819-150-7-200904070-00007
Editorials |  7 April 2009
The Future of Tobacco Treatment in the Health Care System
Nancy A. Rigotti, MD
Ann Intern Med. 2009;150(7):496-497. doi:10.7326/0003-4819-150-7-200904070-00011
Articles |  17 March 2009
Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding
Steven R. Steinhubl, MD; Deepak L. Bhatt, MD, MPH; Danielle M. Brennan, MS; et al.
Ann Intern Med. 2009;150(6):379-386. doi:10.7326/0003-4819-150-6-200903170-00006
Editorials |  17 March 2009
Aspirin for Prevention and Treatment of Cardiovascular Disease
Shamir R. Mehta, MD, MSc
Ann Intern Med. 2009;150(6):414-416. doi:10.7326/0003-4819-150-6-200903170-00011
Editorials |  17 March 2009 FREE
First Do No Harm … Reduction?
Marc N. Gourevitch, MD, MPH
Ann Intern Med. 2009;150(6):417-418. doi:10.7326/0003-4819-150-6-200903170-00111
Advertisement

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)